Advanced Oncotherapy PLC

Receive alerts
Market Cap:
£92.09 m
52 weeks high
52 weeks low

Viewing results 1-25 of 93


Proton beam therapy will become as common as MRI scanning believes Advanced Oncotherapy's chief executive

Nicholas Serandour explains the science and potential of Advanced Oncotherapy's pioneering proton therapy cancer treatment...

1 week, 5 days ago
Retail & consumer

Advanced Oncotherapy secures £18.4mln of additional funding

A total of £14.4mln has come via investors, who paid 40p a share for new stock, which was at a premium to last night’s close. It has also agreed a loan facility with Nerano Pharma...

2 weeks ago

Advanced Oncotherapy on track to treat first patient next year

CEO Nicolas Serandour said: "With the initial hardware manufacturing process and technical design now validated, we remain committed to completing the verification and validation needed to ensure first patient treatment by the end of 2020."...

3 weeks, 6 days ago

Advanced Oncotherapy hails contribution of landlord as development of London proton beam facility passes important milestone

The £10mln of refurbishment costs of the Harley Street facility have been borne by the landlord, The Howard de Walden Estate, which owns and manages a large portfolio of rental properties in London's Marylebone...

4 weeks, 2 days ago

Advanced Oncotherapy: Democratising proton beam therapy

In April, Advanced Oncotherapy PLC (LON:AVO) announced the appointment of Moataz Karmalawy as a chief commercial officer and president of the firm’s US arm. He joined from Varian Particle Therapy, where he served as general manager of the worldwide particle therapy business. Here, in his first interview since joining the......

on 8/7/19

Advanced Oncotherapy on track to treat first cancer patient by end of 2020

Building work at the Harley Street facility is progressing to schedule, and bosses are confident the ground-breaking LIGHT proton beam therapy system will treat its first patient towards the end of next year...

on 28/6/19

Advanced Oncotherapy announces positive results from comparative study

"We have important milestones ahead of us, including our first site in Harley Street which we expect to be soon ready for fit-out, and we reiterate our commitment to treat our first patients towards the end of 2020," said chief executive officer, Nicolas Serandour...

on 3/6/19

Advanced Onco gearing up for commercialisation of its LIGHT proton beam therapy system

Work at Advanced Onco’s Harley Street facility is due to complete within the next few months, and the first patient treated by LIGHT is slated for the second half of 2020...

on 10/5/19

Advanced Oncotherapy secures more than £12mln of additional funding

The company has agreed a debt and equity package that will support continued work to develop its proton beam technology...

on 10/5/19

Advanced Oncotherapy appoints a chief commercial officer and president for its US division

Moataz Karmalawy has served as general manager of the Worldwide Particle Therapy Business for Varian Medical Systems, the world's largest manufacturer of radiotherapy equipment for 12 years...

on 16/4/19

Advanced Oncotherapy rises as it obtains international quality standard for LIGHT system

ISO 13485:2016 is an international quality standard that ensures the consistent design, development, production, installation and sale of medical devices ...

on 21/1/19

Advanced Oncotherapy raises £10mln at a premium

The fundraising is led by Paris-based DNCA Investments which is investing £4.8mln; small change for a company with more than £23bn assets under management...

on 21/12/18

Advanced Oncotherapy rockets as it improves performance of LIGHT cancer treatment system

The firm said the proton beam had reached an energy of 52MeV, double the output energy needed to treat superficial tumours which it reached at the end of last month...

on 10/10/18

Advanced Oncotherapy’s LIGHT system has “fast head start” on changing cancer treatment market, says broker goetzpartners

The broker says the cancer treatment developer could potentially take the entire share of the growth market from ageing cyclotron companies...

on 10/10/18

Advanced Oncotherapy now in a solid position, says research house

AVO is developing a proton beam system that blasts cancer called LIGHT. The initials stand for Linac Image Guided Hadron Technology. The company’s kit is cheaper and smaller than the current units, which are almost prohibitively expensive...

on 2/10/18

Advanced Oncotherapy on track

“We have exciting plans for the future commercialisation of the LIGHT system once completely developed, and our discussions with potential partners around the world are ongoing,” said chief executive Nicolas Serandour...

on 28/9/18

Advanced Oncotherapy passes key technological milestone

Researchers at the CERN facility in Geneva working on the company’s LIGHT system have confirmed it is now generating proton beams with sufficient energy to treat superficial tumours...

on 27/9/18

Advanced Oncotherapy pulls in £6.4mln from Swiss investors

Private banks and healthcare groups took part in the share placing ...

on 2/8/18

Advanced Oncotherapy on track with development of its LIGHT system

The LIGHT system's modularity and linear design lends itself naturally to mass production, shorter manufacturing lead times, easier installation/commissioning and is a technology that offers significant cost and clinical advantages...

on 27/6/18

Advanced Oncotherapy receives final investment payment from Yantai Cipu

The AIM-listed proton therapy developer said the £10mln payment completed Yantai’s £30mln investment in the company...

on 31/5/18

Advanced Oncotherapy refines tumour zapper technology

Advanced Onco's LIGHT system has been designed to electronically control the fast delivery of protons to the tumour site. The company has developed a measurement system that measures the speed of the beam, which allows the system to measure the energy of each proton pulse...

on 29/5/18

Advanced Oncotherapy receives first payment from partner Yantai Cipu

The AIM-listed cancer treatment developer said the £6.5mln payment from Yantai had been received through its affiliated entity Liquid Harmony...

on 11/5/18

Advanced Oncotherapy signs lease for new UK testing and assembly site

The company, a developer of proton therapy systems for cancer treatment, said the facility will become the site of its first fully operational LIGHT system...

on 8/5/18

Advanced Oncotherapy partner extends negotiations for distribution agreement with Chinese firm

The AIM-listed cancer treatment developer said negotiations between Yantai CIPU and the Chinese distributor, conducted through Yantai’s affiliate entity Liquid Harmony, would continue past the originally announced date of 31 March 2018...

on 3/4/18

Advanced Oncotherapy says development of LIGHT system on track

Advanced Oncotherapy has made “significant advancements” in the technological development and manufacture of its LIGHT system...

on 28/12/17